Yahoo
OTC Markets OTCPK - Delayed Quote USD

G Medical Innovations Holdings Ltd (GMVDF)

0.0001 0.0000 (0.00%)
At close: October 30 at 5:00:00 PM EDT
Chart Range Bar
Loading chart for GMVDF
  • Previous Close 0.0001
  • Open 0.0001
  • Bid 0.0071 x --
  • Ask 0.0100 x --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0251
  • Volume 128
  • Avg. Volume 523
  • Market Cap (intraday) 3,347
  • Beta (5Y Monthly) 1,507.05
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2600
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in Israel. The company's products include Prizma, a multi-sensor device that measures vital signs and generate the health trend report; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, the company offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. Further, it provides various accessories for its healthcare products. G Medical Innovations Holdings Ltd was incorporated in 2014 and is based in Rehovot, Israel.

gmedinnovations.com

84

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

GMVDF
50.00%
S&P 500 (^GSPC)
10.73%

1-Year Return

GMVDF
0.00%
S&P 500 (^GSPC)
11.11%

3-Year Return

GMVDF
99.63%
S&P 500 (^GSPC)
81.91%

5-Year Return

GMVDF
100.00%
S&P 500 (^GSPC)
64.59%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -223.32%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    4.42M

  • Net Income Avi to Common (ttm)

    -13.52M

  • Diluted EPS (ttm)

    -0.2600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    295k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -4.87M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: